Antimicrobial activity of cefoperazone-sulbactam tested against Gram-Negative organisms from Europe, Asia-Pacific, and Latin America

Antimicrobial activity of cefoperazone-sulbactam tested against Gram-Negative organisms from Europe, Asia-Pacific, and Latin America

Objectives: To evaluate the antimicrobial activities of cefoperazone-sulbactam and comparator agents tested against a large collection of clinical isolates of Gram-negative organisms. Methods: A total of 19 545 Gram-negative organisms were collected from medical centers located in western Europe (W-...

Full description

Bibliographic Details
Main Authors:	Helio S. Sader, Cecilia G. Carvalhaes, Jennifer M. Streit, Mariana Castanheira, Robert K. Flamm
Format:	Article
Language:	English
Published:	Elsevier 2020-02-01
Series:	International Journal of Infectious Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S120197121930445X

Similar Items

Antimicrobial activity of ceftaroline and comparator agents tested against organisms isolated from patients with community-acquired bacterial pneumonia in Europe, Asia, and Latin America
by: Helio S. Sader, et al.
Published: (2018-12-01)

In Vitro Antimicrobial Activity of Various Cefoperazone/Sulbactam Products
by: Ming-Jen Sheu, et al.
Published: (2020-02-01)

Hypersensitivity vasculitis induced by cefoperazone/sulbactam
by: Ariturk Ender, et al.
Published: (2003-01-01)

Cefoperazone-sulbactam associated refractory seizures
by: Harshad Chovatiya, et al.
Published: (2021-01-01)

Antimicrobial activities of cefoperazone-sulbactam in comparison to cefoperazone against clinical organisms from medical centers in Taiwan
by: Tsung-Ta Chiang, et al.
Published: (2016-01-01)

Evaluation of Piperacillin/Sulbactam, Piperacillin/Tazobactam and Cefoperazone/Sulbactam Dosages in Gram-Negative Bacterial Bloodstream Infections by Monte Carlo Simulation
by: Xueting Wang, et al.
Published: (2023-02-01)

Coagulopathy Induced by Cefoperazone/Sulbactam in a Geriatric Patient
by: Ergenekon Karagoz, et al.
Published: (2015-12-01)

Risk Factors for Cefoperazone/Sulbactam-Induced Coagulation Disorder
by: Miao W, et al.
Published: (2023-09-01)

Hemolytic Anemia and Reactive Thrombocytosis Associated With Cefoperazone/Sulbactam
by: Ling Zhou, et al.
Published: (2019-11-01)

Acute localized exanthematous pustulosis caused by cefoperazone and sodium sulbactam
by: Yan-Jing Qu, et al.
Published: (2016-12-01)

Comparison of commonly used antimicrobial susceptibility testing methods for evaluating susceptibilities of clinical isolates of Enterobacteriaceae and nonfermentative Gram-negative bacilli to cefoperazone–sulbactam
by: Shio-Shin Jean, et al.
Published: (2017-08-01)

Case report: Cefoperazone-sulbactam induced Kounis syndrome and cardiogenic shock
by: Peng Ding, et al.
Published: (2022-11-01)

Glucose-Potentiated Amikacin Killing of Cefoperazone/Sulbactam Resistant Pseudomonas aeruginosa
by: Xi-kang Tang, et al.
Published: (2022-03-01)

The impact of inoculum size on the activity of cefoperazone-sulbactam against multidrug resistant organisms
by: Ping-Chin Chang, et al.
Published: (2018-04-01)

Optimal Dose of Cefoperazone-Sulbactam for Acute Bacterial Infection in Patients with Chronic Kidney Disease
by: Chien-Ming Chao, et al.
Published: (2022-04-01)

Cross-reactivity between piperacillin–tazobactam and cefoperazone–sulbactam in drug-induced immune thrombocytopenia
by: Xiaoyan He, et al.
Published: (2023-03-01)

Comparison of antibiotic-associated diarrhea caused by cefoperazone/sulbactam or piperacillin/tazobactam in neurosurgery patients
by: Yue Chen, et al.
Published: (2021-05-01)

Efficacy of Cefoperazone Sulbactam in Patients with <i>Acinetobacter</i> Infections: A Systematic Review of the Literature
by: Gowthami Sai Kogilathota Jagirdhar, et al.
Published: (2023-03-01)

Development and validation of a nomogram for predicting cefoperazone/sulbactam-induced hypoprothrombinaemia in Hospitalized adult patients
by: Hehe Bai, et al.
Published: (2023-01-01)

Development and validation of a nomogram for predicting cefoperazone/sulbactam-induced hypoprothrombinaemia in Hospitalized adult patients.
by: Hehe Bai, et al.
Published: (2023-01-01)

Differential Proteomic and Genomic Comparison of Resistance Mechanism of Pseudomonas aeruginosa to Cefoperazone Sodium/Sulbactam Sodium
by: SHUANGQI CAI, et al.
Published: (2022-09-01)

Case Report: Drug-Induced Immune Haemolytic Anaemia Caused by Cefoperazone-Tazobactam/ Sulbactam Combination Therapy
by: Yuanjun Wu, et al.
Published: (2021-08-01)

Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Latin America: report from an antimicrobial surveillance program (2013–2015)
by: Michael A. Pfaller, et al.
Published: (2017-11-01)

Clinical Experience with Tigecycline in Combination with Cefoperazon-Sulbactam for Ventilator Associated Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii
by: Nihal PİŞKİN, et al.
Published: (2012-06-01)

Repressed Central Carbon Metabolism and Its Effect on Related Metabolic Pathways in Cefoperazone/Sulbactam-Resistant Pseudomonas aeruginosa
by: Yue-tao Chen, et al.
Published: (2022-03-01)

Outcomes of Adjunctive Therapy with Intravenous Cefoperazone-Sulbactam for Ventilator-Associated Pneumonia Due to Carbapenem-Resistant Acinetobacter baumannii
by: Kanchanasuwan S, et al.
Published: (2021-03-01)

Antimicrobial susceptibility patterns of unusual nonfermentative gram-negative bacilli isolated from Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2002)
by: Ana C Gales, et al.
Published: (2005-10-01)

Risk-factor analysis and predictive-model development of acute kidney injury in inpatients administered cefoperazone-sulbactam sodium and mezlocillin-sulbactam sodium: a single-center retrospective study
by: Ruiqiu Zhang, et al.
Published: (2023-06-01)

Clinical Outcomes and Adverse Effects in Septic Patients with Impaired Renal Function Who Received Different Dosages of Cefoperazone–Sulbactam
by: Chien-Hsiang Tai, et al.
Published: (2022-03-01)

Diminished Susceptibility to Cefoperazone/Sulbactam and Piperacillin/Tazobactam in Enterobacteriaceae Due to Narrow-Spectrum β-Lactamases as Well as Omp Mutation
by: Yang Fengzhen, et al.
Published: (2022-06-01)

Nitrite Promotes ROS Production to Potentiate Cefoperazone-Sulbactam-Mediated Elimination to Lab-Evolved and Clinical-Evolved Pseudomonas aeruginosa
by: Su-fang Kuang, et al.
Published: (2022-08-01)

Corrigendum to “Comparison of commonly used antimicrobial susceptibility testing methods for evaluating susceptibilities of clinical isolates of Enterobacteriaceae and nonfermentative Gram-negative bacilli to cefoperazone-sulbactam” [J Microbiol Immunol Infect (2017) 50: 454–463]
by: Shio-Shin Jean, et al.
Published: (2018-04-01)

Cefoperazone metal complexes and their antimicrobial investigations
by: Mehmet Emin ÇINAR, et al.
Published: (2021-05-01)

Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies
by: Lei Zhang, et al.
Published: (2023-06-01)

Antifungal Activity of Isavuconazole and Comparator Agents against Contemporaneous Mucorales Isolates from USA, Europe, and Asia-Pacific
by: Cecilia G. Carvalhaes, et al.
Published: (2023-02-01)

Spectrum and potency of ceftaroline against leading pathogens causing community-acquired respiratory tract and skin and soft tissue infections in Latin America, 2010
by: Robert K. Flamm, et al.
Published: (2013-09-01)

Antimicrobial susceptibility of quinupristin/dalfopristin tested against gram-positive cocci from Latin America: results from the Global SMART (GSMART) surveillance study
by: Sader Helio S., et al.
Published: (2001-01-01)

Erratum: Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies
by: Frontiers Production Office
Published: (2024-01-01)

Tracking cefoperazone/sulbactam resistance development in vivo in A. baumannii isolated from a patient with hospital-acquired pneumonia by whole-genome sequencing
by: Xiaofen Liu, et al.
Published: (2016-08-01)

Antimicrobial Efficacy of Cefoperazone-Salbactam Plus Tigecycline versus Cefoperazone-Salbactam Against Respiratory Pathogens and Their Effect on Laboratory Indices
by: Sundas Shaukat, et al.
Published: (2023-07-01)